Advances in Oncology, 2024 (Advances)

個数:
電子版価格
¥78,254
  • 電子版あり

Advances in Oncology, 2024 (Advances)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 240 p.
  • 言語 ENG
  • 商品コード 9780443247002
  • DDC分類 616.994

Full Description

Advances in Oncology reviews the year's most important findings and updates within the field in order to provide practicing oncologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.

Contains 26 articles on such topics as management of locoregional melanoma; surgery for recurrent ovarian cancer; advances in pediatric cancer with big data: the Pediatric Cancer Data Commons; advanced imaging in gliomas; approach to minimal residual disease for acute myeloid leukemia; treatment options for HER2-expressing gastroesophageal cancers; and more
Provides in-depth, clinical reviews in oncology, providing actionable insights for clinical practice
Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews

Contents

1. Contemporary Management of Dermatofibrosarcoma Protuberans
2. Management of Locoregional Melanoma
3. Current Management of Intraductal Papillary Mucinous Neoplasms
4. Perioperative Strategies in Non-Small Cell Lung Cancer: Immunotherapy and Targeted Therapy
5. Optimal Front-Line Therapy for Non[1]Oncogene-Driven Non-Small Cell Lung Cancer
6. Beyond First-Line Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKI): Approach to Resistance
7. Antibody-Drug Conjugates for the Treatment of Gynecologic Cancer: A Review of the Current Evidence and Clinical Application
8. Surgery for Recurrent Ovarian Cancer
9. Big Data in Pediatric Oncology: Hope, Hype, Reality
10. Imipridones and Dopamine Receptor Antagonism in the Therapeutic Management of Gliomas
11. Diagnostic and Theranostic Opportunities in Neuro-Oncology
12. Updates on Revised Diagnostic Criteria and Targeted Therapies for Neurofibromatosis
13. Management of Relapsed Refractory Large B[1]Cell Non-Hodgkin Lymphoma: Chimeric Antigen Receptor T-Cell Therapy versus Autologous Stem Cell Transplantation
14. T-cell Acute Lymphoblastic Leukemia: Novel Therapies Worth Watching
15. Prognostic Role and Clinical Utility of Measurable Residual Disease in Acute Myeloid Leukemia
16. Role of Circulating Tumor DNA for Monitoring of Recurrence and Treatment Response in Urothelial Cancer
17. Intensification of Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: 18. Patient Selection and Overview of Doublet and Triplet Therapy Data
19. Adjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Evidence and Future Directions
20. Defining the Role of Neoadjuvant Therapy for Gastroesophageal Cancers
21. Current and Emerging Therapeutic Options for Human Epidermal Growth Factor Receptor 2-Expressing Gastroesophageal Cancers
22. Contemporary Systemic Therapy Approaches for Unresectable Hepatocellular Carcinoma
23. Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma

最近チェックした商品